Who is Anjani Sinha, the Indian-origin surgeon nominated by Donald Trump as Singapore's ambassador?
Dr. Anjani Sinha, President
Donald Trump
's nominee for U.S. Ambassador to Singapore, faced pointed criticism during his Senate confirmation hearing on July 9, after failing to answer several fundamental questions about the Southeast Asian nation and U.S.
strategic interests in the Indo-Pacific region.
Senator Tammy Duckworth pressed a seasoned orthopedic surgeon with no prior diplomatic experience, Sinha, on Singapore's trade surplus with the U.S., its role in ASEAN, and the strategic presence of the U.S. Navy in the region. His responses were inconsistent and at times inaccurate.
The exchange quickly became tense, with Duckworth accusing Sinha of viewing the posting as a 'glamour job,' saying: 'You are not currently prepared for this posting, period, and you need to shape up and do some homework.'
She added, 'You think this is a glamour posting, that you're going to live a nice life in Singapore, when what we need is someone who can actually do the work.'
Who is Anjani Sinha?
Despite the controversy surrounding his nomination, Dr. Anjani Sinha has had a long and accomplished career in medicine and business. He is a highly respected orthopedic surgeon and entrepreneur who has built multiple thriving medical practices across the United States.
Early Life and Education
Born in Bihar, India, Dr. Sinha earned his medical degree from Mahatma Gandhi Medical College. In 1972, he relocated to New Delhi, completing his residency at Safdarjung Hospital, affiliated with Delhi University and the Central Institute of Orthopaedics.
In 1979, Dr. Sinha migrated to the United States. He interned at top institutions including Mount Sinai Medical Center and Long Island Jewish Medical Center, gaining a strong foundation in American medical practice.
He would later specialize in orthopedic surgery and sports medicine.
Career
Dr. Sinha has established a prominent presence on the East Coast, building key-man orthopedic and surgical practices across eight locations in New York. He has also served as a senior surgical consultant in Florida. His work spans both the public and private sectors, interfacing with professionals across healthcare, business, and legal fields.
Family and personal life
Dr. Sinha has been married for 48 years to Dr. Kuntala 'Kiki' Sinha, a retired anesthesiologist and former faculty member at NYU. The couple became U.S. citizens in the mid-1990s after immigrating together in 1979.
They have two children, Pooja (born 1981) and Sumeet (born 1983), both born in the United States. The Sinhas have embraced education as a core family value. Pooja is an alumna of Dartmouth and Harvard, while Sumeet studied at New York University and Columbia.
They now have three grandchildren.
As per The Edge Singapore, Dr. Sinha retains strong cultural and familial ties to India and the broader Indo-Pacific region. His extended family includes connections to Yashwant Sinha, a former Indian finance minister and the Opposition's candidate in India's 2022 presidential election.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
7 minutes ago
- India Today
US assisting in Cambodia-Thailand talks, conflict needs to end: Marco Rubio
US Secretary of State Marco Rubio said American officials are in Malaysia to help mediate talks between Cambodia and Thailand, in order to bring an end to the conflict between the two neighbouring countries."Cambodia and Thailand are scheduled to begin high-level talks in Malaysia shortly in hopes of achieving an immediate ceasefire. State Department officials are on the ground in Malaysia to assist these peace efforts," Rubio said in a statement released on also confirmed that both he and President Donald Trump are closely involved in monitoring the situation. "Both President Donald Trump and I remain engaged with our respective counterparts for each country and are monitoring the situation very closely. We want this conflict to end as soon as possible," he added. WHY THE TALKS MATTER The meeting comes as tensions between Thailand and Cambodia have escalated. Both countries have blamed each other for launching artillery attacks across disputed border areas. Talks in Malaysia mark the first major diplomatic effort to ease the violence that escalated over the past few conflict intensified in late May when a Cambodian soldier was killed during a brief skirmish. Troops on both sides of the border were reinforced amid a full-blown diplomatic crisis that brought Thailand's fragile coalition government to the brink of resumed last Thursday and quickly turned into the worst military clash between the two Southeast Asian neighbours in over ten far, more than 30 people have died in the clashes, including 13 civilians in Thailand and 8 in Cambodia. Officials said over 200,000 people have been forced to flee from border regions to avoid the THREATENS TO HALT TRADE DEALSUS President Trump said on Sunday that both Cambodia and Thailand had agreed to begin negotiations after he warned their leaders that continuing the conflict could hurt future US trade deals. However, Cambodia and Thailand each said the other had launched artillery attacks across contested border areas early on revealed that he personally spoke with Cambodian Prime Minister Hun Manet and Thailand's acting Prime Minister Phumtham said he made it clear that ongoing violence would jeopardize trade agreements with the US. "I told both leaders that if the fighting doesn't stop, we will not move forward with any trade deals. We believe both sides want peace, and we're doing everything we can to support that," Trump said in a Truth Social of Monday, the Cambodian and Thai leaders are scheduled to meet face-to-face in Kuala Lumpur for direct talks. The acting Prime Minister Phumtham Wechayachai will lead the negotiating team, the Thai government said in a statement. Talks are scheduled to begin at 3 pm local time (0700 GMT).- EndsWith inputs from ReutersTune InMust Watch
New Indian Express
7 minutes ago
- New Indian Express
US and China to talk in Stockholm on trade with eye on Trump-Xi summit later this year
Fentanyl-related tariffs are likely a focus for China In Stockholm, Beijing will likely demand the removal of the 20% fentanyl-related tariff that Trump imposed earlier this year, said Sun Yun, director of the China program at the Washington-based Stimson Center. This round of the U.S.-China trade dispute began with fentanyl, when Trump in February imposed a 10% tariff on Chinese goods, citing that China failed to curb the outflow of the chemicals used to make the drug. The following month, Trump added another 10% tax for the same reason. Beijing retaliated with extra duties on some U.S. goods, including coal, liquefied natural gas, and farm products such as beef, chicken, pork and soy. In Geneva, both sides climbed down from three-digit tariffs rolled out following Trump's "Liberation Day" tariffs in April, but the U.S. kept the 20% "fentanyl" tariffs, in addition to the 10% baseline rate — to which China responded by keeping the same 10% rate on U.S. products. These across-the-board duties were unchanged when the two sides met in London a month later to negotiate over non-tariff measures such as export controls on critical products. The Chinese government has long protested that American politicians blame China for the fentanyl crisis in the U.S. but argued the root problem lies with the U.S. itself. Washington says Beijing is not doing enough to regulate precursor chemicals that flow out of China into the hands of drug dealers. In July, China placed two fentanyl ingredients under enhanced control, a move seen as in response to U.S. pressure and signaling goodwill. Gabriel Wildau, managing director at the consultancy Teneo, said he doesn't expect any tariff to go away in Stockholm but that tariff relief could be part of a final trade deal. "It's possible that Trump would cancel the 20% tariff that he has explicitly linked with fentanyl, but I would expect the final tariff level on China to be at least as high as the 15-20% rate contained in the recent deals with Japan, Indonesia, Vietnam," Wildau said.
Time of India
26 minutes ago
- Time of India
Prostate cancer: 7 myths that can delay cancer diagnosis in men
When it comes to men's health, prostate cancer tends to fly under the radar—until it doesn't. Prostate cancer is one of the most common cancers in American men, second only to skin cancer. And yet, myths and misunderstandings still cloud how we talk about it, test for it, and treat it. From the idea that it only affects "older guys" to the belief that early signs of prostate cancer always come with obvious symptoms (spoiler: they usually don't), misinformation can be dangerous. Worse, it often leads to delays in diagnosis and prostate cancer treatment—and time matters when dealing with any cancer. Whether you're in your 40s or your 70s, knowing the facts about prostate health is just smart self-care. What is Prostate Cancer? Prostate cancer starts in the prostate gland, a small, walnut-sized part of the male reproductive system that sits just below the bladder. But sometimes, the cells in the prostate start growing out of control. That's when cancer kicks in. The tricky part is that prostate cancer symptoms often don't show up early. Most guys feel totally fine, no pain, no warning signs, nothing. That's why regular prostate cancer screening, including PSA tests and yes, the digital rectal exam, matter. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Indonesia: Unsold Sofas Prices May Surprise You (Prices May Surprise You) Sofas | Search Ads Search Now Undo In many cases, prostate cancer is highly treatable, especially when caught early. But if left undetected, it can spread to bones, lymph nodes, and other areas. That's why keeping tabs on your prostate health, especially after age 50, is a game-changer. Think of it as part of long-term men's cancer awareness—your future self will thank you. Myth: 'If I don't have symptoms, I don't have prostate cancer.' Sorry, wish it were true! The sneaky thing about prostate cancer is that in the early stages, it usually has no symptoms at all. Nope, not even a twinge or a peep. When symptoms like trouble peeing or back pain do pop up, it usually means the cancer has already advanced. That's why screening and talking to your doc (even when you feel perfectly fine) is so important, especially if you're over 50, African-American, or have a family history of prostate cancer. Myth: 'Only old men get prostate cancer.' Sure, risk increases as you get older—most cases happen in men over 65. But younger men can and do get prostate cancer, sometimes even in their forties or fifties. Bottom line: age is a big risk factor, but it's not a guarantee. No matter your age, be aware of your personal risk and talk it over with your health provider. Myth: 'If my dad had it, I'm doomed.' Having a father (or brother) with prostate cancer definitely bumps up your risk—about double, in fact. But it's not destiny; plenty of men with a strong family history never get prostate cancer. And on the flip side, about 90% of prostate cancers pop up in men with no family history at all. Your family history is important to know, but it's not a crystal ball. Myth: 'Screenings and PSA tests are pointless (or will always lead to unnecessary treatment).' Screening is controversial, but it's not pointless! The PSA (prostate-specific antigen) blood test can catch cancer before symptoms show up, but it's not foolproof. Some cancers are slow, harmless guests; others need action, fast. If you have an elevated PSA, that's just one piece of the puzzle, not an automatic cancer diagnosis or reason to rush into treatment. Decisions should always be personal, based on your age, health, and family history—and in conversation with your doctor. Myth: 'If I have prostate cancer, I need treatment right now.' Not all prostate cancers are aggressive or dangerous. Some are so slow-growing that your doctor may recommend 'active surveillance'—keep an eye on things with regular tests and only step in if the situation changes. For many men, avoiding or delaying treatment means fewer side effects, while still staying safe. Myth: 'Treatments always ruin your sex life and cause incontinence.' Treatments can have side effects, including trouble with erections and urinary issues—you've probably heard this a lot. But not every guy who gets treated ends up with long-term problems. Side effects depend on many factors: your age, the specific treatment, and even the experience of your healthcare team. Plus, treatments and support to help manage side effects are better than ever. Myth: 'If you don't eat sugar or take special vitamins, you won't get prostate cancer.' Let's clear the air: eating sugar doesn't cause prostate cancer, and there's no magic diet or supplement that can prevent it. Obesity is linked to a higher risk of several cancers, including prostate, so eating healthy matters, but skipping sugar or popping vitamins won't give you a get-out-of-cancer card.
